Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PvCSP Vaccine Efficacy in Naïve and Semi-immune Volunteers
NCT04739917Phase 2Unknown
- Sponsor
- Malaria Vaccine and Drug Development Center
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in malaria (4 arms), sponsored by Malaria Vaccine and Drug Development Center. Primary endpoint: Frequency of first case of P. vivax malaria after CHMI. Status: unknown.
02
Conditions
malaria
Beyond the preview
Go deeper on NCT04739917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739917.